Signing out of account, Standby...
Theranos - Page: 4
When startups fail, founders don't get an 'A' for effort. That's not how it works in the real world -- certainly not when lives are at stake.
The FDA, two state departments of health and The Centers for Medicare and Medicaid have also opened probes against the company.
Government says the company failed to fix deficiencies at its California laboratory.
Data confirms that the company knew its finger pin-prick tests were often wrong when it used them in October, 2014.
The higher number of abnormal test results, researchers wrote, 'can have negative consequences for medicine in the form of extra testing, additional patient visits to clinics/hospitals, and added doctor services.'
Eighty one patients in a six-month period received hematology results that were not adequately controlled for quality.
After one of Theranos' labs was found to pose immediate jeopardy to patient safety, Walgreens has ordered that no blood tests be analyzed there.
The embattled blood-testing startup's lab practices were found to be deficient.
The findings could lead to Theranos' suspension from the Medicare program.
The investigations follow complaints filed by two former Theranos employees, casting even greater doubt upon the honesty and accuracy of the $9 billion blood test startup.
The partnership, code-named project 'T-Rex,' called for Theranos blood test facilities to be built in 800 Safeway stores nationwide.